Kappa-Opioid Settings: Real-World Evidence Insights
Lucio Manenti, MD, PhD
Emilio Sanchez, MD, PhD
Is CKD-aP Hiding in Your Dialysis Center?
James Burton, DM, FRCP
Elevating CKD-aP Care: New Frontier
CKD-aP Treatment Tool Kit
Leonie Kraft, MD
Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
Jürgen Floege, MD
Future Directions in Managing Hyperkalemia in CKD and HF
Javed Butler, MD, MPH, MBA
The Critical Interplay: CKD, HF, and Hyperkalemia
Javed Butler, MD
Ellie Kelepouris, MD, FACP, FAHA
Patrick Rossignol, MD, PhD
Potassium Binders: Safety Comes First!
Potassium Binders in Practice: Clinical Trial Evidence
The Clinical Weight of TTR: What the Latest Data Reveal
Ahmad Masri, MD, MS
Rola Khedraki, MD
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
Daniel Judge, MD
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
Kevin Alexander, MD
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
VNS: Beyond Seizure Control
Raman Sankar, MD, PhD
Scott Aaronson, MD
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression